Intellia Therapeutics Head office building

SEC Filing
Details

Document Details

Form
Filing Date
Nov 7, 2022
Document Date
Nov 5, 2022
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.